KACTUS Blog

ENPP3: A Potential Target for Tumor Therapy with Broad Prospects
ENPP3: A Potential Target for Tumor Therapy with Broad Prospects
TCE Antibody Screening Applying Native-like KACTUS TCR-CD3 Complexes to Drug Discovery
TCE Antibody Screening Applying Native-like KACTUS TCR-CD3 Complexes to Drug Discovery
Why CD3 Remains the Gold Standard: Clinical Momentum and the Protein Quality Imperative
Why CD3 Remains the Gold Standard: Clinical Momentum and the Protein Quality Imperative
KACTUS Launches CD3-TCR Complex VLP Products
KACTUS Launches CD3-TCR Complex VLP Products
c-MET: A Key Target in Cancer Therapy
c-MET: A Key Target in Cancer Therapy
From Oncology to Autoimmunity: The “Old” Target CD20 Still Holds Great Promise
From Oncology to Autoimmunity: The “Old” Target CD20 Still Holds Great Promise
The Landscape of GPCR-targeting Antibody Drug Development
The Landscape of GPCR-targeting Antibody Drug Development
Nanodiscs: A Versatile Platform for Membrane Protein Research
Nanodiscs: A Versatile Platform for Membrane Protein Research
Case Review: Exploring domain proteins in antibody development
Case Review: Exploring domain proteins in antibody development
1 2

Explore more

  • Antibody Drug Discovery
  • Assay Kits
  • Cell Therapy
  • Company News
  • Gene Editing
  • GPCRs
  • Membrane Proteins
  • MHC/TCR
  • Product Highlights
  • Recombinant Proteins
  • RNA/DNA
  • VLP & Nanodisc Proteins
  • VLP and Nanodisc Proteins
  • VLP Proteins

    • Popular posts

    Beyond Refolding: The Case for Mammalian-Expressed Single-Chain Trimer MHCs
    Beyond Refolding: The Case for Mammalian-Expressed Single-Chain Trimer MHCs
    Sep 18, 2024
    IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme
    IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme
    Jul 24, 2024